The antidepressant effects of 5-HT uptake inhibitorsABERG-WISTEDT, A.British journal of psychiatry (Print). 1989, Vol 155, pp 32-40, issn 0007-1250, suppl. 8Conference Paper

A DOUBLE-BLIND STUDY OF ZIMELIDINE, A SEROTONIN UPTAKE INHIBITOR, AND DESIPRAMINE, A NORADRENALINE UPTAKE INHIBITOR, IN ENDOGENOUS DEPRESSIONABERG WISTEDT A; ROSS SB; JOSTELL KG et al.1982; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1982; VOL. 66; NO 1; PP. 66-82; BIBL. 2 P.Article

EFFECTS OF ZIMELIDINE AND DESIPRAMINE ON SEROTONIN AND NORADRENALINE UPTAKE MECHANISMS IN RELATION TO PLASMA CONCENTRATIONS AND TO THERAPEUTIC EFFECTS DURING TREATMENT OF DEPRESSIONABERG WISTEDT A; JOSTELL KG; ROSS SB et al.1981; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1981; VOL. 74; NO 4; PP. 297-305; BIBL. 1 P.Article

Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolitesMALMGREN, R; ABERG-WISTEDT, A; BERTILSSON, L et al.Psychopharmacologia. 1987, Vol 92, Num 2, pp 169-172, issn 0033-3158Article

Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia : a randomized controlled trialMORTBERG, E; CLARK, D. M; SUNDIN, O et al.Acta psychiatrica Scandinavica. 2007, Vol 115, Num 2, pp 142-154, issn 0001-690X, 13 p.Article

Glucuronidation of amitriptyline in man in vivoDAHL-PUUSTINEN, M.-L; ABERG-WISTEDT, A; BERTILSSON, L et al.Pharmacology & toxicology. 1989, Vol 65, Num 1, pp 37-39, issn 0901-9928Article

Platelet serotonergic functions and light therapy in seasonal affective disorderSTAIN-MALMGREN, R; KJELLMAN, B. F; ABERG-WISTEDT, A et al.Psychiatry research. 1998, Vol 78, Num 3, pp 163-172, issn 0165-1781Article

Fluoxetine inhibits the metabolism of tolterodine-pharmacokinetic implications and proposed clinical relevanceBRYNNE, N; SVANSTRÖM, C; ABERG-WISTEDT, A et al.British journal of clinical pharmacology. 1999, Vol 48, Num 4, pp 553-563, issn 0306-5251Article

Two-year outcome of team-based intensive case management for patients with schizophreniaABERG-WISTEDT, A; CRESSELL, T; LIDBERG, Y et al.Psychiatric services (Washington, D.C.). 1995, Vol 46, Num 12, pp 1263-1266, issn 1075-2730Article

Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomesBERTILSSON, L; ABERG-WISTEDT, A; LIDEN, A et al.Therapeutic drug monitoring. 1988, Vol 10, Num 2, pp 231-233, issn 0163-4356Article

Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldineABERG-WISTEDT, A; ALVARIZA, M; BERTILSSON, L et al.Acta psychiatrica Scandinavica. 1985, Vol 71, Num 3, pp 256-268, issn 0001-690XArticle

Serotonergic function in major depression and effect of sertraline and paroxetine treatmentSTAIN-MALMGREN, R; EL KHOURY, A; ABERG-WISTEDT, A et al.International clinical psychopharmacology. 2001, Vol 16, Num 2, pp 93-101, issn 0268-1315Article

Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patientsBERTILSSON, L; OTANI, K; DAHL, M.-L et al.Pharmacology & toxicology. 1991, Vol 68, Num 2, pp 100-103, issn 0901-9928, 4 p.Article

Impaired neuropsychological performance in euthymic patients with recurring mood disordersTHAM, A; ENGELBREKTSON, K; MATHE, A. A et al.The Journal of clinical psychiatry. 1997, Vol 58, Num 1, pp 26-29, issn 0160-6689Article

Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderWAGNER, A; ABERG-WISTEDT, A; ASBERG, M et al.Archives of general psychiatry. 1987, Vol 44, Num 10, pp 870-877, issn 0003-990XArticle

An educational program on depressive disorders for general practitioners on Gotland: background and evaluationRUTZ, W; WALINDER, J; EBERHARD, G et al.Acta psychiatrica Scandinavica. 1989, Vol 79, Num 1, pp 19-26, issn 0001-690XArticle